Geode Capital Management LLC Grows Stock Holdings in RenovoRx, Inc. (NASDAQ:RNXT)

Geode Capital Management LLC raised its position in shares of RenovoRx, Inc. (NASDAQ:RNXT) by 61.9% during the third quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 232,937 shares of the company’s stock after purchasing an additional 89,018 shares during the period. Geode Capital Management LLC owned approximately 0.97% of RenovoRx worth $247,000 at the end of the most recent reporting period.

Wall Street Analysts Forecast Growth

Separately, Ascendiant Capital Markets raised their price target on RenovoRx from $8.25 to $9.00 and gave the company a “buy” rating in a research report on Tuesday, December 10th.

RenovoRx Trading Up 1.5 %

RNXT opened at $1.35 on Tuesday. The company has a market cap of $32.40 million, a P/E ratio of -2.37 and a beta of 1.09. The business’s 50-day moving average price is $1.25 and its 200-day moving average price is $1.14. RenovoRx, Inc. has a 12 month low of $0.77 and a 12 month high of $1.86.

RenovoRx Profile

RenovoRx, Inc, a clinical-stage biopharmaceutical company, focuses on developing proprietary targeted combination therapies to improve therapeutic outcomes for cancer patients undergoing treatment. Its lead product candidate is RenovoGem, an oncology drug-device combination product, consisting of intra-arterial gemcitabine and RenovoCath that is in Phase III clinical trials for the locally advanced pancreatic cancer.